Inhibition of poly(ADP-ribose) synthetase potentiates cell dacarbazine cytotoxicity.
Dacarbazine induces DNA lesions in cells synthesizing new DNA. When poly(ADP-ribosylation) is inhibited with 3-aminobenzamide, repair of the dacarbazine-induced DNA lesions is reduced. This is parallelled by increased cytotoxicity. Cells pre-treated with aphidicolin (to stop DNA synthesis) are resistant to dacarbazine.